The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts
Abstract
Traditional drug development consists of a sequence of independent trials organized in different phases. Full development typically involves (i) a learning phase II trial and (ii) one or two confirmatory phase III trial(s). For example, in the phase II trials several doses of the new compound might be compared to a control and/or placebo with the goal of deciding whether to stop or continue development and, in the latter case, selecting one or two “best” doses to carry forward into the confirmatory phase. The phase III trials are then conducted as stand‐alone confirmatory studies, not incorporating in their statistical analyses data collected in the previous phases. Seamless phase II/III designs are aimed at interweaving the two phases of full development by combining them into one single, uninterrupted study conducted in two stages. In the dose‐finding example above, one (or more) dose(s) are selected after the first stage based on the available data at interim, and are then observed further in the second stage. The final analysis of the selected dose(s) includes patients from both stages and is performed such that the overall type I error rate is controlled at a pre‐specified level regardless of the dose selection rule used at interim. The adequacy of the dose selection at interim is obviously a critical step for the success of a seamless phase II/III trial. In this paper we focus on the description of flexible test procedures allowing for adaptively selecting hypotheses at interim and thus allowing the combination of learning and confirming in a single seamless trial. We review the statistical background, introduce different test procedures and compare them in a power study. In a subsequent paper (Schmidli et al., 2006) we give several applications from our daily practice and discuss related implementation issues in conducting adaptive seamless designs. (© 2006 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multiple Comparison Procedure for Comparing Several Treatments with a Control
Dunnett, C. W. (1955) · Journal of the American Statistical Association · doi:10.1080/01621459.1955.10501294 · Cited by 6,094
On closed testing procedures with special reference to ordered analysis of variance
MARCUS, R., ERIC, P., & GABRIEL, K. R. (1976) · Biometrika · doi:10.1093/biomet/63.3.655 · Cited by 1,423
Evaluation of Experiments with Adaptive Interim Analyses
Bauer, P., & Kohne, K. (1994) · Biometrics · doi:10.2307/2533441 · Cited by 865
Adaptive Sample Size Calculations in Group Sequential Trials
Lehmacher, W., & Wassmer, G. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.01286.x · Cited by 598
Modification of Sample Size in Group Sequential Clinical Trials
Cui, L., Hung, H. M. J., & Wang, S. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00853.x · Cited by 574
Designed Extension of Studies Based on Conditional Power
Proschan, M. A., & Hunsberger, S. A. (1995) · Biometrics · doi:10.2307/2533262 · Cited by 534
Multiple Comparisons and Multiple Tests Using the SAS System
ROM, D. M., Tobias, R. D., & Wolfinger, R. D. (1999) · Cited by 436
Müller, H.-H., & Schäfer, H. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.00886.x · Cited by 372
Combining different phases in the development of medical treatments within a single trial
Bauer, P., & Kieser, M. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990730)18:14<1833::aid-sim221>3.0.co;2-3 · Cited by 287
Brannath, W., Posch, M., & Bauer, P. (2002) · Journal of the American Statistical Association · doi:10.1198/016214502753479374 · Cited by 240
Cited by
Adaptive designs for confirmatory clinical trials
Bretz, F., Koenig, F., Brannath, W., Glimm, E., & Posch, M. (2009) · Statistics in Medicine · doi:10.1002/sim.3538 · Cited by 266
Self-citationPhase II Trials in Drug Development and Adaptive Trial Design
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.02.005 · Cited by 133
“This has led to calls for the development and acceptance of “seamless” trials— strategies that in effect allow a phase II trial to fold seamlessly into a phase III trial by combining elements and data analysis of both in a single innovative trial design (36,37).”
BackgroundDose finding—a challenge in statistics.
Bretz, F., Hsu, J., Pinheiro, J., & Liu, Y. (2008) · Biometrical Journal · doi:10.1002/bimj.200810438 · Cited by 101
Self-citationDimairo, M., Pallmann, P., Wason, J., Todd, S., Jaki, T., Julious, S. A., Mander, A. P., Weir, C. J., Koenig, F., Walton, M. K., et al. (2020) · Trials · doi:10.1186/s13063-020-04334-x · Cited by 58
Metadata
- Authors
- Bretz, F., Schmidli, H., König, F., Racine, A., & Maurer, W.
- Venue
- Biometrical Journal
- Publisher
- Wiley
- Published
- 2006-08
- Volume
- 48
- Issue
- 4
- Pages
- 623-634
- ISSN
- 0323-3847 (ISSN-L)
- 1521-4036
- OpenAlex
- W2033969681
- Cited by
- 272
- References
- 14
- FWCI
- 12.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts. https://app.cochat.ai/papers/10.1002/bimj.200510232
- The paper
- Bretz, F., Schmidli, H., König, F., Racine, A., & Maurer, W. (2006). Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts. Biometrical Journal. https://doi.org/10.1002/bimj.200510232
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.